|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | ||
| Adjustments to reconcile net income to cash provided by operating activities: | ||
| Depreciation and amortization | ||
| Stock based compensation | ||
| Gain on marketable securities, net | ||
| Gain on CLS Sale | ||
| Gain on sale leaseback of German warehouse | ||
| Noncash charges for interest and bond discount amortization | ||
| Loss on repayment of term loans | ||
| Amortization of lease right-of-use asset | ||
| Deferred income taxes | ||
| Loss (gain) on foreign exchange | ||
| Loss on sale of subsidiaries | ||
| Other | ||
| Changes in operating assets and liabilities, net of effects of acquisitions: | ||
| Trade accounts receivable | ||
| Inventory | ||
| Other assets | ||
| Accounts payable | ||
| Change in book overdrafts | ||
| Operating lease liabilities | ||
| Accrued expenses and other | ||
| Cash provided by operating activities | ||
| Cash flows from investing activities: | ||
| Capital expenditures | ||
| Proceeds from deferred purchase price of factored receivables | ||
| Sale (purchase) of marketable securities, net | ||
| Issuance of notes receivable | ||
| Proceeds from note receivables | ||
| Proceeds from sale of subsidiaries | ||
| Proceeds from sale leaseback of German warehouse | ||
| Proceeds from sale of equity investments | ||
| Other | ||
| Cash provided by (used in) investing activities | ||
| Cash flows from financing activities: | ||
| Payment of contingent consideration related to Imola Mergers | ||
| Dividends paid to shareholders | ||
| Change in unremitted cash collections from servicing factored receivables | ||
| Proceeds from issuance of common stock in initial public offering, net of underwriting discounts | ||
| Repayment of term loans | ||
| Gross proceeds from other debt | ||
| Gross repayments of other debt | ||
| Net (repayments of) proceeds from revolving and other credit facilities | ||
| Repurchase of common stock for tax withholdings on equity awards | ||
| Purchase of Colsof shares | ||
| Other | ||
| Cash used in financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Cash and cash equivalents classified within held for sale | ||
| Increase (decrease) in cash and cash equivalents | ||
| Cash and cash equivalents, beginning of year | ||
| Cash and cash equivalents, end of year | ||
| Supplemental disclosures of cash flow information: | ||
| Interest | ||
| Income taxes | ||
| Supplemental disclosure of non-cash investing and financing information: | ||
| Proceeds not yet received from CLS sale | ||
| Amounts obtained as a beneficial interest in exchange for transferring trade receivables in factoring arrangements |
Loading...
